Description
Rapid SARS-CoV-2/Influenza A+B Antigen Duo Test Card is an immunochromatography based one step in vitro test. It is designed for the rapid qualitative determination of SARS-CoV-2 viral antigen in nasopharyngeal swabs from individuals suspected of COVID-19 by their healthcare provider within the first seven days of symptom onset and influenza type A and type B viral antigens in nasopharyngeal swab specimens. Rapid SARS-CoV-2/Influenza A+B Antigen Duo Test Card can not be used as the basis to diagnose or exclude SARS-CoV-2 infection and influenza infection.
